You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, April 2021
|
| DOI | 10.1186/s13063-021-05180-1 |
| Pubmed ID | |
| Authors |
Murat Akova, Serhat Unal |
X Demographics
The data shown below were collected from the profiles of 82 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 15% |
| Indonesia | 7 | 9% |
| Canada | 5 | 6% |
| Turkey | 3 | 4% |
| Colombia | 2 | 2% |
| Argentina | 2 | 2% |
| Germany | 1 | 1% |
| Australia | 1 | 1% |
| Philippines | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 45 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 72 | 88% |
| Scientists | 8 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 327 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 327 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 10% |
| Student > Bachelor | 32 | 10% |
| Researcher | 24 | 7% |
| Student > Ph. D. Student | 21 | 6% |
| Other | 13 | 4% |
| Other | 60 | 18% |
| Unknown | 144 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 21% |
| Nursing and Health Professions | 34 | 10% |
| Biochemistry, Genetics and Molecular Biology | 11 | 3% |
| Social Sciences | 11 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 2% |
| Other | 42 | 13% |
| Unknown | 152 | 46% |